GSK Biologicals' investigational vaccine GSK2340274A (alternative formulations)
114000
Phase 3 mab completed
Quick answer
GSK Biologicals' investigational vaccine GSK2340274A (alternative formulations) for Influenza is a Phase 3 program (mab) at GlaxoSmithKline with 1 ClinicalTrials.gov record(s).
Program details
- Company
- GlaxoSmithKline
- Indication
- Influenza
- Phase
- Phase 3
- Modality
- mab
- Status
- completed